<p>Serum from BALB/cByJ mice vaccinated s.c. with influenza A/PR8 and either infected or not with Bb was harvested at 9 weeks after vaccination/infection and transferred i.v into individual recipient mice. Shown is % weight loss of individual recipients as a measure of protective capacity of the serum after i.v. serum adoptive transfer and i.n. infection with A/PR8. Each line represents one mouse, which was the recipient of serum from one donor mouse. P<0.01 was determined using paired one-tailed Student’s <i>t</i> test.</p
<p>A) Mice were primed with LCMV Armstrong and then given serum from X31-GP33 immune mice, naïve mic...
BALB/c mice received an intraperitoneal injection of different volumes of anti-NA or anti-HA immune ...
The immunogenicities of inactivated whole and split virus vaccines derived from influenza A/H1N1pdm0...
<p>Recipient mice received serum (A and B) CD4+T cells (C and D) or CD8+T cells (E and F) obtained f...
<p>Kaplan-Meier survival curves (left), mean bodyweight change (middle) and median clinical score (r...
<p>Serum anti-influenza IgG antibody titers. Serum influenza specific IgG titers (ng/ml). The immuni...
<p>Mice were vaccinated with Ad5-IiOva and 40 days later, serum (immune serum) was transferred to na...
<p>A–B: Protection against A/California/04/2009 virus challenge. Mice intramuscularly immunized with...
<p>(A) Mice (n = 8/group) were immunized once with TVV+MM or PBS as negative control 4 weeks before ...
<p>Groups of 5 B6 mice were treated with purified (A) anti-Ly6G (1A8) or (B) anti-Gr-1 (RB6-8C5) ant...
<p>Vaccinated RAG-1<sup>−/−</sup> mice (◊) or vaccinated RAG-1<sup>−/−</sup> mice that received naïv...
<p>Groups of three to four mice each were vaccinated at days 0, 14, 28 and 126 (downward pointing op...
<p>(<b>A</b>) Serum was obtained from 25 human subjects immediately prior to the first vaccination a...
<p>(a) J8-specific IgG concentrations in serum of individual donor and recipient mice are shown, wit...
<p>Mice were immunised once by the i.n. (squares), s.c. (triangles) or i.m. (circles) routes with 10...
<p>A) Mice were primed with LCMV Armstrong and then given serum from X31-GP33 immune mice, naïve mic...
BALB/c mice received an intraperitoneal injection of different volumes of anti-NA or anti-HA immune ...
The immunogenicities of inactivated whole and split virus vaccines derived from influenza A/H1N1pdm0...
<p>Recipient mice received serum (A and B) CD4+T cells (C and D) or CD8+T cells (E and F) obtained f...
<p>Kaplan-Meier survival curves (left), mean bodyweight change (middle) and median clinical score (r...
<p>Serum anti-influenza IgG antibody titers. Serum influenza specific IgG titers (ng/ml). The immuni...
<p>Mice were vaccinated with Ad5-IiOva and 40 days later, serum (immune serum) was transferred to na...
<p>A–B: Protection against A/California/04/2009 virus challenge. Mice intramuscularly immunized with...
<p>(A) Mice (n = 8/group) were immunized once with TVV+MM or PBS as negative control 4 weeks before ...
<p>Groups of 5 B6 mice were treated with purified (A) anti-Ly6G (1A8) or (B) anti-Gr-1 (RB6-8C5) ant...
<p>Vaccinated RAG-1<sup>−/−</sup> mice (◊) or vaccinated RAG-1<sup>−/−</sup> mice that received naïv...
<p>Groups of three to four mice each were vaccinated at days 0, 14, 28 and 126 (downward pointing op...
<p>(<b>A</b>) Serum was obtained from 25 human subjects immediately prior to the first vaccination a...
<p>(a) J8-specific IgG concentrations in serum of individual donor and recipient mice are shown, wit...
<p>Mice were immunised once by the i.n. (squares), s.c. (triangles) or i.m. (circles) routes with 10...
<p>A) Mice were primed with LCMV Armstrong and then given serum from X31-GP33 immune mice, naïve mic...
BALB/c mice received an intraperitoneal injection of different volumes of anti-NA or anti-HA immune ...
The immunogenicities of inactivated whole and split virus vaccines derived from influenza A/H1N1pdm0...